Literature DB >> 1257615

Effects of subtoxic lead levels on pregnant women in the state of Missouri.

M S Fahim, Z Fahim, D G Hall.   

Abstract

Cords, placentas, placental membranes, and maternal and fetal blood were collected from 249 women delivered in Columbia, Missouri (Region I). The same samples were obtained from 253 women delivered in Rolla, Missouri (Region II), near lead mining areas. The incidence of term pregnancies with early membrane rupture was 0.41% in Region I and 17% in Region II. The incidence of premature deliveries was 3% and 13.04% respectively. Lead concentration in blood and placental tissues of term pregnancies revealed no significant changes. In term with early membrane rupture, blood concentration of lead was higher, as was the case in placental tissues and cord. Lead concentration was highest in membrane tissues, in mug/100 grams (Regions I and II respectively): placenta, 6.0 +/- 0.01 and 7.0 +/- 0.03; cord, 11.0 +/- 0.34 and 12.0 +/- 0.18; membrane, 38.9 +/- 2.64 and 45.3 +/- 3.12. A high positive correlation (r = 0.2941) between lead concentration in maternal and fetal blood existed. Both were significantly (P less than 0.01) higher in preterm pregnancies and early membrane ruptures than in term pregnancies. These data suggest that subtoxic levels of lead could increase the incidence of early membrane rupture and premature deliveries.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1257615

Source DB:  PubMed          Journal:  Res Commun Chem Pathol Pharmacol        ISSN: 0034-5164


  13 in total

1.  The Port Pirie cohort study: maternal blood lead and pregnancy outcome.

Authors:  A J McMichael; G V Vimpani; E F Robertson; P A Baghurst; P D Clark
Journal:  J Epidemiol Community Health       Date:  1986-03       Impact factor: 3.710

2.  Lead concentration in the livers of Canadians.

Authors:  B G Shah; B Belonje
Journal:  Bull Environ Contam Toxicol       Date:  1978-10       Impact factor: 2.151

Review 3.  Lead intoxication.

Authors:  L S Ibels; C A Pollock
Journal:  Med Toxicol       Date:  1986 Nov-Dec

4.  Very low prenatal exposure to lead and mental development of children in infancy and early childhood: Krakow prospective cohort study.

Authors:  Wieslaw Jedrychowski; Frederica P Perera; Jeffery Jankowski; Dorota Mrozek-Budzyn; Elzbieta Mroz; Elzbieta Flak; Susan Edwards; Anita Skarupa; Ilona Lisowska-Miszczyk
Journal:  Neuroepidemiology       Date:  2009-02-18       Impact factor: 3.282

Review 5.  The hazard evaluation system and information service: a physician's resource in toxicology and occupational medicine.

Authors:  K Hooper
Journal:  West J Med       Date:  1982-12

6.  Prenatal low-level lead exposure and developmental delay of infants at age 6 months (Krakow inner city study).

Authors:  Wieslaw Jedrychowski; Frederica Perera; Jeffery Jankowski; Virginia Rauh; Elzbieta Flak; Kathleen L Caldwell; Robert L Jones; Agnieszka Pac; Ilona Lisowska-Miszczyk
Journal:  Int J Hyg Environ Health       Date:  2007-10-01       Impact factor: 5.840

Review 7.  Mercury, cadmium, and lead levels in human placenta: a systematic review.

Authors:  María D Esteban-Vasallo; Nuria Aragonés; Marina Pollan; Gonzalo López-Abente; Beatriz Perez-Gomez
Journal:  Environ Health Perspect       Date:  2012-05-16       Impact factor: 9.031

8.  Lead in the placenta, membranes, and umbilical cord in relation to pregnancy outcome in a lead-smelter community.

Authors:  P A Baghurst; E F Robertson; R K Oldfield; B M King; A J McMichael; G V Vimpani; N R Wigg
Journal:  Environ Health Perspect       Date:  1991-01       Impact factor: 9.031

Review 9.  Possibilities of detecting health effects by studies of populations exposed to chemicals from waste disposal sites.

Authors:  P A Buffler; M Crane; M M Key
Journal:  Environ Health Perspect       Date:  1985-10       Impact factor: 9.031

10.  The Yugoslavia Prospective Study of environmental lead exposure.

Authors:  P Factor-Litvak; G Wasserman; J K Kline; J Graziano
Journal:  Environ Health Perspect       Date:  1999-01       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.